Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Rang în acțiuni #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Preț acțiune
$28.53
Capitalizare de piață
$1.96B
Schimbare (1 zi)
-1.65%
Schimbare (1 an)
109.32%
Țară
IE
Tranzacționează GH Research PLC (GHRS)

Categorie

Istoricul spliturilor pentru GH Research PLC (GHRS)
Acțiunea GH Research PLC (simbol: GHRS) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 28, 2026.
O acțiune GHRS cumpărată înainte de Aug 28, 2026 este echivalentă astăzi cu 0 acțiuni GHRS.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH